BeOne Medicines (BEIGF) EBT Margin Growth (5y) (2020 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EBT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.93 Bn | 625.17 Bn | 17.26 Bn |
| 2 | AbbVie | 443.06 Bn | 436.49 Bn | 12.70 Bn |
| 3 | Merck | 365.76 Bn | 358.62 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.47 Bn | 258.78 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.36 Bn | 44.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - |
| 8 | Incyte | 25.42 Bn | 20.88 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33,872.00 |
| Mar 31, 2026 | 692.00 |
| Dec 31, 2025 | 49,146.00 |
| Sep 30, 2025 | 48,807.00 |
| Jun 30, 2025 | 52,222.00 |
| Mar 31, 2025 | 69,990.00 |
| Dec 31, 2024 | 66,095.00 |
| Sep 30, 2024 | 61,219.00 |
| Jun 30, 2024 | 2,305.00 |
| Mar 31, 2024 | 18,288.00 |
| Dec 31, 2023 | 41,387.00 |
| Sep 30, 2023 | 29,680.00 |
| Jun 30, 2023 | 24,333.00 |
| Mar 31, 2023 | 25,824.00 |
| Dec 31, 2022 | 40,585.00 |
| Sep 30, 2022 | -19,408.00 |
| Jun 30, 2021 | 578,367.00 |
| Mar 31, 2021 | 325,349.00 |
| Dec 31, 2020 | 10,114.00 |
| Sep 30, 2020 | 53,677.00 |